Development of AstraZeneca’s neutrality strategy

AstraZeneca, the global pharmaceutical company, unveiled in early 2020 its ‘Ambition Zero Carbon’ plan, an ambitious programme that will see the company become zero emissions by 2025, as well as ensuring that its entire value chain has a negative carbon footprint by 2030.

Global Factor has collaborated in the “Neutrality Strategy” of AstraZeneca in Spain, starting from the calculation of its carbon footprint. Thanks to this calculation it was possible to identify key indicators for any report made by the organization, as well as actions that are being developed with the aim of saving energy consumption, raw materials, etc.

Subsequently, a climate change and climate neutrality plan were defined for AstraZeneca Spain, which included specific and customised targets and measures to reduce CO2.